Publication | Open Access

Cell-active, irreversible covalent inhibitors that selectively target the catalytic lysine of EGFR by using fluorosulfate-based SuFEx chemistry

Medicinal ChemistryDrug TargetingBiochemistryIrreversible Covalent InhibitorsNatural SciencesMedicinePolymer-drug ConjugateCatalytic LysineTumor TargetingDrug DevelopmentChemical BiologyPharmacologyFluorosulfate-based Sufex ChemistryDrug Discovery